A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS

Trial Profile

A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2014

At a glance

  • Drugs WF 10 (Primary)
  • Indications Allergic rhinitis
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 28 Apr 2012 Additional lead trial investigator (Christian Gessner) identified as reported by ClinicalTrials.gov.
    • 28 Apr 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01586468).
    • 24 Mar 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top